병원체 감소 시스템 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 용도별, 제품별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Pathogen Reduction Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Product, By End User, By Region & Competition, 2020-2030F
상품코드:1785319
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 188 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 병원체 감소 시스템 시장은 2024년 7억 1,906만 달러가 되었고, 2030년까지 CAGR 8.00%로 확대되어 예측 기간 중 눈부신 성장이 예측되고 있습니다.
병원체는 인체에 심각한 감염이나 질병을 일으킬 수 있는 유해한 미생물입니다. 수혈 중 감염 위험을 줄이기 위해 병원체 감소 시스템이 사용됩니다. 이 시스템은 혈장, 적혈구, 혈소판과 같은 혈액과 혈액 제형에서 병원체를 불활성화하거나 제거하는 다양한 프로세스와 기술을 포함합니다. 오염된 혈액은 유해한 면역 반응을 유발하거나 추가 합병증을 유발할 수 있으므로 이러한 제품의 안전성을 보장하는 것은 면역계가 약한 환자에게 수혈할 때 특히 중요합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
7억 1,906만 달러
시장 규모 : 2030년
11억 3,199만 달러
CAGR : 2025-2030년
8.00%
급성장 부문
혈소판 병원체 감소
최대 시장
북미
병원체 감소의 주요 목적은 수혈로 인한 감염의 위험을 최소화하여 혈액 공급의 안전성을 높이는 것입니다. 이를 달성하기 위해 몇 가지 고급 방법이 채택되었습니다. 그 중에서도 자외선(UV)과 광화학 치료가 널리 사용되고 있습니다. 이러한 기술은 병원체의 핵산(DNA 또는 RNA)을 손상시켜 병원체의 복제나 해의 발생을 효과적으로 방지하는 것입니다. 광화학 치료에서는 혈액 제제에 감광성 화합물을 첨가하는 경우가 많으며, 이 화합물은 자외선에 노출되면 병원체의 유전 물질과 상호작용하여 기능이 중단됩니다. UV 기반 기술 외에도, 여과 방법도 병원체 감소에 중요한 역할을 합니다. 혈액을 특수 박테리아 필터에 통과시켜 병원체를 물리적으로 차단하고 필요한 혈액 성분을 통과시킬 수 있습니다. 이러한 방법을 결합하면 수혈된 혈액이 가능한 한 안전하고 병원체를 포함하지 않도록 보장할 수 있습니다. 병원체 감소 기술을 도입함으로써 건강 관리 시스템은 수혈 중 질병 감염 위험을 크게 줄일 수 있으므로 환자의 건강을 보호하고 특히 면역 결핍 환자에 대한 결과를 향상시킬 수 있습니다.
주요 시장 성장 촉진요인
감염관리에 대한 의식의 고조와 중시
주요 시장 과제
기술의 복잡성과 비용
주요 시장 동향
첨단 기술과 혁신
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 병원체 감소 시스템 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
유형별(혈소판 병원체 감소, 혈장 병원체 감소)
용도별(바이러스, 진균, 세균)
제품별(자동, 반자동)
최종 사용자별(병원 클리닉, 외래 진료 센터, 혈액은행, 기타)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
시장 맵
제6장 북미의 병원체 감소 시스템 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 병원체 감소 시스템 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 병원체 감소 시스템 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 병원체 감소 시스템 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 병원체 감소 시스템 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
제13장 세계의 병원체 감소 시스템 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
산업 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Terumo BCT, Inc.
Macopharma SA
Cerus Corporation
AngioDynamics, Inc.
Octapharma AG
제16장 전략적 제안
제17장 기업 소개와 면책사항
JHS
영문 목차
영문목차
Global Pathogen Reduction Systems Market was valued at USD 719.06 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.00% through 2030. Pathogens are harmful microorganisms capable of causing serious infections and diseases in the human body. To mitigate the risk of transmitting infections during transfusions, a pathogen reduction system is utilized. This system includes a range of processes and technologies designed to inactivate or remove pathogens from blood and blood products such as plasma, red blood cells, and platelets. Ensuring the safety of these products is especially critical when transfusing patients with weakened immune systems, as contaminated blood could trigger adverse immune responses or lead to further complications.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 719.06 Million
Market Size 2030
USD 1131.99 Million
CAGR 2025-2030
8.00%
Fastest Growing Segment
Platelet Pathogen Reduction
Largest Market
North America
The main goal of pathogen reduction is to enhance the safety of the blood supply by minimizing the risk of transfusion-transmitted infections. Several advanced methods are employed to achieve this. Among them, ultraviolet (UV) light and photochemical treatments are widely used. These techniques work by damaging the nucleic acids (DNA or RNA) of pathogens, effectively preventing them from replicating and causing harm. Photochemical treatments often involve adding a photosensitive compound to the blood product, which, when exposed to UV light, interacts with the pathogen's genetic material, rendering it non-functional. In addition to UV-based technologies, filtration methods also play a key role in pathogen reduction. These involve passing blood through specialized bacterial filters designed with pore sizes small enough to physically block pathogens while allowing essential blood components to pass through. Together, these methods help ensure that transfused blood is as safe and pathogen-free as possible. By implementing pathogen reduction technologies, healthcare systems can significantly reduce the risk of disease transmission during transfusion, thereby safeguarding patient health and improving outcomes, especially for immunocompromised individuals.
Key Market Drivers
Increasing Awareness and Emphasis on Infection Control
Increasing awareness and emphasis on infection control have a significant influence on the growth of the global pathogen reduction systems market. As awareness about the risks and consequences of infections grows, there is a higher demand for effective infection control solutions. For instance, on June 2025, Cerus Corporation (NASDAQ:CERS) participated in the Goldman Sachs 46th Annual Global Healthcare Conference. CEO Obi Greenman highlighted the company's strategic focus on pathogen reduction technologies and the growing adoption of its INTERCEPT blood system. Despite a solid financial foundation and market leadership, Cerus continues to navigate challenges related to expanding market penetration and securing regulatory approvals. Pathogen reduction systems are essential tools in combating the spread of infections in various settings, including healthcare facilities, food processing industries, and public spaces. The emphasis on infection control drives the adoption of these systems, resulting in market growth. Governments and regulatory bodies worldwide have implemented stringent standards and guidelines related to infection control. Compliance with these regulations necessitates the use of pathogen reduction systems in various industries. The awareness of these requirements drives organizations to invest in and implement these systems to ensure compliance and maintain public health and safety. HAIs pose a significant risk to patients, healthcare providers, and the healthcare system as a whole. Increasing awareness of the prevalence and impact of HAIs has led to a greater emphasis on infection control in healthcare settings. Pathogen reduction systems play a crucial role in minimizing the risk of HAIs by eliminating or reducing the presence of pathogens. The focus on infection control in healthcare drives the demand for these systems. Outbreaks of infectious diseases, such as the COVID-19 pandemic, have highlighted the critical importance of infection control and prevention. Governments, healthcare organizations, and other institutions are now prioritizing the preparedness and response to such outbreaks. Pathogen reduction systems are considered essential tools in mitigating the spread of diseases during outbreaks, resulting in increased adoption and market growth. Consumers are becoming more conscious of the risks associated with infections, especially in the context of food safety and public spaces. They expect businesses and establishments to prioritize infection control measures and provide safe environments. This consumer awareness and expectation drive the demand for pathogen reduction systems in industries such as food processing, hospitality, and public facilities. Increased awareness of the importance of infection control has led to collaborative efforts among governments, healthcare organizations, and educational institutions to educate the public about best practices. These initiatives raise awareness about the role of pathogen reduction systems and their effectiveness in preventing the spread of infections. As a result, there is greater acceptance and adoption of these systems, contributing to market growth.
Key Market Challenges
Technological Complexity and Cost
Developing and implementing effective pathogen reduction technologies can be complex and costly. The research, development, and testing of these systems require significant resources, which can impact their affordability and accessibility, especially for small-scale producers. Adhering to strict regulatory standards and guidelines is crucial for pathogen reduction systems, particularly in the food industry. Meeting and maintaining these regulations can be challenging due to evolving standards and variations in requirements across different regions and countries. Introducing new pathogen reduction methods can sometimes face resistance from consumers who might be concerned about the impact of these processes on the sensory qualities, nutritional value, or overall safety of the products.
Key Market Trends
Advanced Technologies and Innovation
The pathogen reduction systems market is likely to see continuous advancements in technologies such as nanotechnology, advanced filtration, and new chemical treatments. These innovations could lead to more efficient and targeted pathogen reduction methods. The integration of Internet of Things (IoT) technology and smart sensors could enable real-time monitoring, data collection, and control of pathogen reduction processes. This could enhance system efficiency, reduce waste, and improve response times to potential issues. Pathogen reduction systems could be integrated more seamlessly into global supply chains, ensuring the safety of products as they move across various stages of production, distribution, and consumption.
Key Market Players
Terumo BCT, Inc.
Macopharma SA.
Cerus Corporation.
AngioDynamics, Inc.
Octapharma AG.
Report Scope:
In this report, the Global Pathogen Reduction Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pathogen Reduction Systems Market, By Type:
Platelet Pathogen Reduction
Plasma Pathogen Reduction
Pathogen Reduction Systems Market, By Application:
Viruses
Fungi
Bacteria
Pathogen Reduction Systems Market, By Product:
Automated
Semi-Automated
Pathogen Reduction Systems Market, By End User:
Hospitals & Clinics
Ambulatory Care centers
Blood Banks
Others
Pathogen Reduction Systems Market, By Region:
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.
Available Customizations:
Global Pathogen Reduction Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pathogen Reduction Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
5.2.2. By Application (Viruses, Fungi, Bacteria)
5.2.3. By Product (Automated, Semi-Automated)
5.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.6. By Company (2024)
5.3. Market Map
6. North America Pathogen Reduction Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
6.2.2. By Application (Viruses, Fungi, Bacteria)
6.2.3. By Product (Automated, Semi-Automated)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pathogen Reduction Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. Canada Pathogen Reduction Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By Product
6.3.2.2.4. By End User
6.3.3. Mexico Pathogen Reduction Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By Product
6.3.3.2.4. By End User
7. Europe Pathogen Reduction Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
7.2.2. By Application (Viruses, Fungi, Bacteria)
7.2.3. By Product (Automated, Semi-Automated)
7.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Pathogen Reduction Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Pathogen Reduction Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Pathogen Reduction Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Pathogen Reduction Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By Product
7.3.5.2.4. By End User
8. Asia-Pacific Pathogen Reduction Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
8.2.2. By Application (Viruses, Fungi, Bacteria)
8.2.3. By Product (Automated, Semi-Automated)
8.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pathogen Reduction Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. India Pathogen Reduction Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. Japan Pathogen Reduction Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By Product
8.3.3.2.4. By End User
8.3.4. South Korea Pathogen Reduction Systems Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By Product
8.3.4.2.4. By End User
8.3.5. Australia Pathogen Reduction Systems Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By Product
8.3.5.2.4. By End User
9. South America Pathogen Reduction Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
9.2.2. By Application (Viruses, Fungi, Bacteria)
9.2.3. By Product (Automated, Semi-Automated)
9.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pathogen Reduction Systems Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. Argentina Pathogen Reduction Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Colombia Pathogen Reduction Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By Product
9.3.3.2.4. By End User
10. Middle East and Africa Pathogen Reduction Systems Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
10.2.2. By Application (Viruses, Fungi, Bacteria)
10.2.3. By Product (Automated, Semi-Automated)
10.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pathogen Reduction Systems Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By Product
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Pathogen Reduction Systems Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By Product
10.3.2.2.4. By End User
10.3.3. UAE Pathogen Reduction Systems Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By Product
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Pathogen Reduction Systems Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1 Terumo BCT, Inc.
15.2 Macopharma SA.
15.3 Cerus Corporation.
15.4 AngioDynamics, Inc.
15.5 Octapharma AG.
16. Strategic Recommendations
17. About Us & Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
